Phenotyping of drug metabolism in infants and children: potentials and problems.
作者信息
Rane A
机构信息
Department of Clinical Pharmacology, University Hospital, Uppsala, Sweden.
出版信息
Pediatrics. 1999 Sep;104(3 Pt 2):640-3.
PMID:10469807
Abstract
摘要
相似文献
1
Phenotyping of drug metabolism in infants and children: potentials and problems.
Pediatrics. 1999 Sep;104(3 Pt 2):640-3.
2
[Status of pharmacogenomics and its future role in drug therapy].[药物基因组学的现状及其在药物治疗中的未来作用]
Internist (Berl). 2002 Apr;43(4):506-10. doi: 10.1007/s00108-002-0558-0.
3
[Individualization of drug therapy and pharmacogenetics].[药物治疗个体化与药物遗传学]
Nihon Rinsho. 1998 Mar;56(3):579-83.
4
Populations and genetic polymorphisms.
Mol Diagn. 1999 Dec;4(4):299-307. doi: 10.154/MODI00400299.
5
[Genetic polymorphism of drug metabolizing enzymes].[药物代谢酶的基因多态性]
Seikagaku. 1997 Oct;69(10):1196-9.
6
Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.药物代谢酶的基因多态性：日本人CYP2D6和CYP2A6基因中的新突变
Pharm Res. 1998 Apr;15(4):517-24. doi: 10.1023/a:1011913407147.
7
[Genetic polymorphisms of drug metabolizing enzymes].[药物代谢酶的基因多态性]
Gan To Kagaku Ryoho. 2002 May;29(5):663-8.
8
Pharmacogenetics of cytochromes P450.细胞色素P450的药物遗传学
Mol Aspects Med. 1999 Feb-Apr;20(1-2):12-24, 25-137. doi: 10.1016/s0098-2997(99)00005-9.
9
How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?使用细胞色素P450表型探针在体内评估人类肝脏药物代谢能力的“鸡尾酒法”有多大用处？
J Clin Pharm Ther. 2003 Jun;28(3):157-65. doi: 10.1046/j.1365-2710.2003.00486.x.
10
Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.药物代谢中的性别差异：细胞色素P-450和尿苷二磷酸葡萄糖醛酸转移酶
J Gend Specif Med. 2002 Jan-Feb;5(1):25-33.
引用本文的文献
1
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.评价兰索拉唑作为评估儿童细胞色素 P450 2C19 活性和表型-基因型相关性的探针。
Eur J Clin Pharmacol. 2012 May;68(5):629-36. doi: 10.1007/s00228-011-1151-z. Epub 2011 Nov 11.
2
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.预测新生儿、婴儿和儿童体内11种药物的清除率及相关变异性。
Clin Pharmacokinet. 2006;45(9):931-56. doi: 10.2165/00003088-200645090-00005.
3
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.婴儿肝脏和肾脏全身清除途径的个体发生：第一部分。
Clin Pharmacokinet. 2002;41(12):959-98. doi: 10.2165/00003088-200241120-00003.
4
Pharmacogenetic tactics and strategies: implications for paediatrics.药物遗传学策略与战术：对儿科的影响
Paediatr Drugs. 2001;3(12):863-81. doi: 10.2165/00128072-200103120-00001.
Zotero 插件